alendronate - CISMeF

Preferred Label : alendronate;

MeSH definition : A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.;

MeSH synonym : 4-amino-1-hydroxybutylidene 1,1-biphosphonate; aminohydroxybutane bisphosphonate;

CISMeF synonym : 121268-17-5 (Alendronate sodium); 4 amino 1 hydroxybutylidene 1,1 biphosphonate; alendronate monosodium salt, trihydrate; bisphosphonate, aminohydroxybutane; sodium, alendronate;

Wikipedia automatic translation : Alendronic acid;

MeSH hyponym : alendronate sodium;

Related MeSH term : MK-217; fosamax; MK 217; MK217;

MeSH Related Number : alendronate sodium; 121268-17-5 (mono-Na salt, trihydrate); 66376-36-1 (Alendronate); 2UY4M2U3RA;

Registry Number MeSH : 66376-36-1;

Related CAS MeSH : 2UY4M2U3RA (Alendronate sodium);

Wikipedia link : https://en.wikipedia.org/wiki/Alendronic acid;

Is substance : O;

UNII : X1J18R4W8P;

InChIKey : OGSPWJRAVKPPFI-UHFFFAOYSA-N;

Details

Origin ID

D019386;

UMLS CUI

C0102118;

ATC code(s)
- alendronic acid, calcium and colecalciferol, sequential [ATC Code]
ATC code(s)
- alendronic acid [ATC Code]
- alendronic acid and alfacalcidol, sequential [ATC Code]
- alendronic acid and colecalciferol [ATC Code]
- alendronic acid, calcium and colecalciferol, sequential [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- bone density conservation agents [MeSH Descriptor]
Record concept(s)
- Alendronate Monosodium Salt, Trihydrate [MeSH concept]
- MK-217 [MeSH concept]
- alendronate [MeSH concept]
- alendronate sodium [MeSH concept]
- fosamax [MeSH concept]
Related MeSH Supplementary Concept(s)
- (3-amino-1-(dimethoxyphosphoryl)-1-hydroxypropyl)phosphonic acid dimethyl ester [MeSH Supplementary Concept]
- 5-FdU-alendronate [MeSH Supplementary Concept]
- N-myristoylalendronic acid [MeSH Supplementary Concept]
- maxmarvil [MeSH Supplementary Concept]
- prolyl-phenylalanyl-alendronate [MeSH Supplementary Concept]
- technetium tc 99m alendronate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Alendronate [LOINC component]
- Alendronate (substance) [SNOMED CT concept]
- alendronate [SNOMED Notion]
Validated automatic mappings to BTNT
- Alendronate Sodium [NCIt concept]
- Alendronate sodium [SMS substance]
- Alendronate sodium (substance) [SNOMED CT concept]
- alendronate sodium [Substance BNPC]
- alendronic acid [ATC Code]
Validated automatic mappings to NTBT
- Alendronic acid (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients